University of Alberta
History
COVID-19
U of A received a $46,585 CAD grant in July 2021 from the Government of Canada for a project titled “WISEST: Building Confidence in Vaccines in Girls and Young Women in Canada.”1) It was awarded through a grant program called “Encouraging Vaccine Confidence in Canada” jointly administered by the Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council (NSERC) and the Social Sciences and Humanities Research Council (SSHRC).2)
In March 2022, the University announced the creation of the Pfizer Applied Clinical Pharmacology Program under the Faculty of Pharmacy and Pharmaceutical Sciences. The new program is in partnership with Pfizer and Applied Pharmaceutical Innovation (API).3)
Organization
Metabolic and Cardiovascular Diseases Laboratory
U of A's MCDL has previously received research funding from:4)
- Advanced Foods and Materials Network (AFMNet)
- Alberta Health Services (AHS)
- Beef Information Centre (BIC)
1)
Encouraging vaccine confidence in Canada - Competition Results. (2021, July 26). Natural Sciences and Engineering Research Council of Canada (NSERC). Retrieved November 3, 2021, from https://archive.ph/Zo5b5
2)
Encouraging vaccine confidence in Canada. (2021, July 26). Natural Sciences and Engineering Research Council of Canada. Retrieved November 3, 2021, from https://www.nserc-crsng.gc.ca/Promoter-Promotion/VaccineConfidence_eng.asp
3)
Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program. (2022, March 16). Applied Pharmaceutical Innovation. https://web.archive.org/web/20221026202112/https://appliedpharma.ca/pfizer-applied-pharmaceutical-innovation-and-university-of-alberta-launch-the-pfizer-applied-clinical-pharmacology-program/
4)
Previous Funding Partners. Metabolic and Cardiovascular Diseases Laboratory. Retrieved October 26, 2022, from https://web.archive.org/web/20221026204817/https://mcvd.ualberta.ca/research/previous-funding-partners/